Neurotherapy: Rewiring the Brain | Golden Age

Neurotherapy, also known as neurofeedback or biofeedback, is a type of therapy that utilizes real-time brain activity feedback to help individuals self-regulate and modify their brain function. This approach has been used to treat a range of conditions, including attention deficit hyperactivity disorder (ADHD), anxiety, depression, and post-traumatic stress disorder (PTSD). According to a study published in the Journal of Neurotherapy, neurofeedback has been shown to be effective in reducing symptoms of ADHD in children, with a 2018 meta-analysis revealing a significant reduction in inattention and hyperactivity. The use of neurotherapy has been influenced by key figures such as Dr. Joe Kamiya, who is often credited with developing the first neurofeedback training protocol in the 1960s. With a vibe score of 8, indicating a high level of cultural energy, neurotherapy is a rapidly evolving field, with advancements in technology and research continuing to shape its development. As of 2022, neurotherapy has become increasingly recognized as a viable treatment option, with the American Psychological Association (APA) acknowledging its potential benefits. However, controversy surrounds the field, with some critics arguing that the evidence base is not yet robust enough to support its widespread adoption, highlighting the need for further research and debate.